Johnson & Johnson says COVID-19 vaccine 85 per cent effective against severe illness
OTTAWA -- American pharmaceutical giant Johnson and Johnson says its vaccine is very good at preventing people from being hospitalized or dying from COVID-19.
The vaccine is the first to use just a single dose and can be stored in a fridge for up to three months, making it a potential game changer in the COVID-19 vaccination campaign.
The results aren't quite as good as those seen in the two vaccines Health Canada has already approved, with both Pfizer-BioNTech and Moderna saying their vaccines showed 95 per cent efficacy against severe illness.
Johnson and Johnson says it's single-dose vaccine is 85 per cent effective against severe illness a month after the injection is given, and 66 per cent effective against both moderate and severe illness.
The federal government has already pre-purchased 10 million doses of the vaccine, but it is still being reviewed by Health Canada.
There is no timeline yet for when approval might come or when those doses would be delivered for use in Canada.
- Health Canada approves AstraZeneca’s COVID-19 vaccine
- Provinces doing ‘extraordinary’ job to avoid wasting doses of COVID-19 vaccine
- First doses of Pfizer COVID-19 vaccine, not yet approved, to land in Canada next week
- Canada to receive record 640K vaccine doses this week with Pfizer, Moderna deliveries
- Canada signs deals with two suppliers for potential COVID-19 vaccines
- International travelers are walking out of Mississauga's Pearson Airport and ignoring quarantine rules
- Brampton school sends 18 staff members home over COVID-19 scare
- 49 fines issued for travellers refusing COVID-19 test at Mississauga's Pearson Airport; Peel police won't issue further fines
- Some elderly Brampton and Mississauga residents can get COVID-19 vaccines much sooner than expected
- Mississauga and Brampton schools get hit by the COVID-19 variants